Membrane proximal ectodomain cleavage of MUC16 occurs in the acidifying Golgi/post-Golgi compartments

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Das, Srustidhar ^a   Majhi, Prabin D ^a   Al Mugotir, Mona H ^a   Rachagani, Satyanarayana ^a   Sorgen, Paul ^a   Batra, Surinder K ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; LEUKOCYTE ELASTASE; MATRILYSIN; MEMBRANE PROTEIN; MUC16 PROTEIN, HUMAN;

ANIMAL; CELL MEMBRANE; CHEMISTRY; GENETICS; GLYCOSYLATION; GOLGI COMPLEX; HUMAN; INTRACELLULAR SPACE; METABOLISM; MOUSE; PH; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN STABILITY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; CA-125 ANTIGEN; CELL MEMBRANE; GLYCOSYLATION; GOLGI APPARATUS; HUMANS; HYDROGEN-ION CONCENTRATION; INTRACELLULAR SPACE; LEUKOCYTE ELASTASE; MATRIX METALLOPROTEINASE 7; MEMBRANE PROTEINS; MICE; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STABILITY; PROTEIN TRANSPORT; PROTEOLYSIS; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 84930648648     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09759     Document Type: Article

References (46)

1. Hollingsworth,M.A. &Swanson, B. J. Mucins in cancer: protection and control of the cell surface. Nat. Rev. Cancer 4, 45-60 (2004).
2. Kufe, D. W. Mucins in cancer: function, prognosis and therapy. Nat. Rev. Cancer 9, 874-885 (2009).
3. Senapati, S., Das, S. & Batra, S. K. Mucin-interacting proteins: from function to therapeutics. Trends Biochem. Sci. 35, 236-245 (2010).
4. Mai, P. L., Wentzensen, N. & Greene, M. H. Challenges related to developing serum-based biomarkers for early ovarian cancer detection. Cancer. Prev. Res. (Phila) 4, 303-306 (2011).
5. Einama, T. et al. Co-expression of mesothelin and CA125 correlates with unfavorable patient outcome in pancreatic ductal adenocarcinoma. Pancreas 40, 1276-1282 (2011).
6. Streppel, M. M. et al. Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon. Hum. Pathol. 43, 1755-1763 (2012).
7. Shimizu, A. et al. Coexpression of MUC16 and mesothelin is related to the invasion process in pancreatic ductal adenocarcinoma. Cancer. Sci. 103, 739-746 (2012).
8. Hattrup, C. L. & Gendler, S. J. Structure and function of the cell surface (tethered) mucins. Annu. Rev. Physiol. 70, 431-457 (2008).
9. Govindarajan, B. & Gipson, I. K. Membrane-tethered mucins have multiple functions on the ocular surface. Exp. Eye Res. 90, 655-663 (2010).
10. Duraisamy, S., Ramasamy, S., Kharbanda, S. & Kufe, D. Distinct evolution of the human carcinoma-associated transmembrane mucins, MUC1, MUC4 AND MUC16. Gene 373, 28-34 (2006).
11. Wreschner, D. H. et al. Generation of ligand-receptor alliances by "SEA"modulemediated cleavage of membrane-associated mucin proteins. Protein Sci. 11, 698-706 (2002).
12. Macao, B., Johansson, D. G., Hansson, G. C. & Hard, T. Autoproteolysis coupled to protein folding in the SEA domain of themembrane-bound MUC1 mucin. Nat. Struct. Mol. Biol. 13, 71-76 (2006).
13. Akhavan, A., Crivelli, S. N., Singh, M., Lingappa, V. R. & Muschler, J. L. SEA domain proteolysis determines the functional composition of dystroglycan. FASEB J. 22, 612-621 (2008).
14. O'Brien, T. J. et al. The CA 125 gene: an extracellular superstructure dominated by repeat sequences. Tumour Biol. 22, 348-366 (2001).
15. Theriault, C. et al. MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis. Gynecol. Oncol. 121, 434-443 (2011).
16. Boivin, M., Lane, D., Piche, A. & Rancourt, C. CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic druginduced apoptosis. Gynecol. Oncol. 115, 407-413 (2009).
17. Akita, K. et al. CA125/MUC16 interacts with Src family kinases, and overexpression of its C-terminal fragment in human epithelial cancer cells reduces cell-cell adhesion. Eur. J. Cell Biol. 92, 257-263 (2013).
18. Matte, I., Lane, D., Boivin, M., Rancourt, C. & Piche, A. MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression. BMC Cancer 14, 234-2407-14-234 (2014).
19. Blalock, T. D., Spurr-Michaud, S. J., Tisdale, A. S. & Gipson, I. K. Release of membrane-associated mucins from ocular surface epithelia. Invest. Ophthalmol. Vis. Sci. 49, 1864-1871 (2008).
20. Govindarajan, B. et al. A metalloproteinase secreted by Streptococcus pneumoniae removes membrane mucin MUC16 from the epithelial glycocalyx barrier. PLoS One 7, e32418 (2012).
21. Felder, M. et al. MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress. Mol. Cancer 13, 129-4598-13-129 (2014).
22. Berek, J. S. et al. Randomized, placebo-controlled study of oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer. J. Clin. Oncol. 22, 3507-3516 (2004).
23. Sabbatini, P. et al. Abagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO - the MIMOSA study. J. Clin. Oncol. 31, 1554-1561 (2013).
24. Das, S. et al. Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells. Oncotarget (2015).
25. Patnaik, S. K. & Stanley, P. Lectin-resistant CHO glycosylation mutants. Methods Enzymol. 416, 159-182 (2006).
26. Mumm, J. S. et al. A ligand-induced extracellular cleavage regulates gammasecretase-like proteolytic activation of Notch1. Mol. Cell 5, 197-206 (2000).
27. Sisodia, S. S. & St George-Hyslop, P. H. gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nat. Rev. Neurosci. 3, 281-290 (2002).
28. Xiong, L., Woodward, A. M. & Argueso, P. Notch signaling modulates MUC16 biosynthesis in an in vitro model of human corneal and conjunctival epithelial cell differentiation. Invest. Ophthalmol. Vis. Sci. 52, 5641-5646 (2011).
29. Tousseyn, T. et al. ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase. J. Biol. Chem. 284, 11738-11747 (2009).
30. Urban, S. Making the cut: central roles of intramembrane proteolysis in pathogenic microorganisms. Nat. Rev. Microbiol. 7, 411-423 (2009).
31. Rawson, R. B. et al. Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs. Mol. Cell 1, 47-57 (1997).
32. Fendrick, J. L. et al. CA125 phosphorylation is associated with its secretion from the WISH human amnion cell line. Tumour Biol. 18, 278-289 (1997).
33. Konishi, I., Fendrick, J. L., Parmley, T. H., Quirk, J. G. Jr. & O'Brien, T. J. Epidermal growth factor enhances secretion of the ovarian tumor-associated cancer antigen CA125 from the human amnion WISH cell line. J. Soc. Gynecol. Investig. 1, 89-96 (1994).
34. Colanzi, A. et al. Molecular mechanism and functional role of brefeldin Amediated ADP-ribosylation of CtBP1/BARS. Proc. Natl. Acad. Sci. U. S. A. 110, 9794-9799 (2013).
35. Carew, J. S. Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL. Blood 107, 222; 222-231; 31 (2006).
36. Nakamura, N., Tanaka, S., Teko, Y., Mitsui, K. & Kanazawa, H. Four Na1/H1 exchanger isoforms are distributed to Golgi and post-Golgi compartments and are involved in organelle pH regulation. J. Biol. Chem. 280, 1561-1572 (2005).
37. Axelsson, M. A. et al. Neutralization of pH in the Golgi apparatus causes redistribution of glycosyltransferases and changes in the O-glycosylation of mucins. Glycobiology 11, 633-644 (2001).
38. Leng, Y. et al. Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62. J. Biol. Chem. 282, 19321-19330 (2007).
39. Chapin, H. C., Rajendran, V., Capasso, A. & Caplan, M. J. Detecting the surface localization and cytoplasmic cleavage of membrane-bound proteins. Methods Cell Biol. 94, 223-239 (2009).
40. Bast, R. C. Jr. et al. Reactivity of a monoclonal antibody with human ovarian carcinoma. J. Clin. Invest. 68, 1331-1337 (1981).
41. O'Brien, T. J., Beard, J. B., Underwood, L. J. & Shigemasa, K. The CA 125 gene: a newly discovered extension of the glycosylated N-terminal domain doubles the size of this extracellular superstructure. Tumour Biol. 23, 154-169 (2002).
42. Kim, N., Hong, Y., Kwon, D. & Yoon, S. Somatic mutaome profile in human cancer tissues. Genomics Inform. 11, 239-244 (2013).
43. Davies, J. R., Kirkham, S., Svitacheva,N., Thornton, D. J. & Carlstedt, I. MUC16 is produced in tracheal surface epithelium and submucosal glands and is present in secretions from normal human airway and cultured bronchial epithelial cells. Int. J. Biochem. Cell Biol. 39, 1943-1954 (2007).
44. Dharma Rao, T. et al. Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16. Appl. Immunohistochem. Mol. Morphol. 18, 462-472 (2010).
45. Larsson, D. E. et al. Identification and evaluation of potential anti-cancer drugs on human neuroendocrine tumor cell lines. Anticancer Res. 26, 4125-4129 (2006).
46. Seluanov, A., Vaidya, A. & Gorbunova, V. Establishing primary adult fibroblast cultures from rodents. J. Vis. Exp. 44, e2033 (2010).